Preserved DNA from past clinical trials yields new information about a subtype of alcoholism Charles P. O’Brien Clinical Trials Report 17 October 2008 Pages: 375 - 376
Use of animal models to develop antiaddiction medications Eliot L. Gardner OriginalPaper 17 October 2008 Pages: 377 - 384
Use of stimulants to treat cocaine and methamphetamine abuse F. Gerard MoellerJoy M. SchmitzKimberly L. Kjome OriginalPaper 17 October 2008 Pages: 385 - 391
Novel medications to treat addictive disorders Iván D. MontoyaFrank Vocci OriginalPaper 17 October 2008 Pages: 392 - 398
Training physicians to treat substance use disorders Soteri PolydorouErik W. GundersonFrances R. Levin OriginalPaper 17 October 2008 Pages: 399 - 404
ADD/ADHD and impaired executive function in clinical practice Thomas E. Brown OriginalPaper 17 October 2008 Pages: 407 - 411
Psychosocial treatments for attention-deficit/hyperactivity disorder Laura A. KnightMary RooneyAndrea Chronis-Tuscano OriginalPaper 17 October 2008 Pages: 412 - 418
Attention-deficit/hyperactivity disorder and its comorbidities in women and girls: An evolving picture Patricia O. Quinn OriginalPaper 17 October 2008 Pages: 419 - 423
A clinical review of outcomes of the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA) Desiree W. MurrayL. Eugene ArnoldTara Strauss OriginalPaper 17 October 2008 Pages: 424 - 431
Quantitative electroencephalography and attention-deficit/hyperactivity disorder: Implications for clinical practice Vincent J. Monastra OriginalPaper 17 October 2008 Pages: 432 - 438
Sleep disorders and attention-deficit/hyperactivity disorder Judith A. Owens OriginalPaper 17 October 2008 Pages: 439 - 444